HOME >> MEDICINE >> NEWS
The lancet infectious diseases (TLID) October press release

Bacterial eradication in the treatment of otitis media

Otitis media (middle-ear infection) is a common infectious disease of early childhood; an estimated 20 million cases occur in the USA annually. This review assesses the impact of antibacterial treatment, commenting on how clinicians may become mislead by drug treatment as otitis media often resolves naturally within a few days of infection; the growing problem of widespread antibiotic resistance is also limiting the effectiveness of many therapeutic treatments for the disorder.

Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa?

This review calls for the re-introduction of strategies to target the larvael stage of the anopheles mosquito as part of the global 'Roll Back Malaria' campaign.

OTHER REVIEWS:

Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections

This systematic review and meta-analysis of randomised controlled trials involving more than 5000 women provides further evidence that a cheap and commonly used spermicide gel is not effective in reducing HIV-1 and other sexually transmitted infections.

Staphylococcus aureus disease in drug users
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
4-Oct-2002


Page: 1

Related medicine news :

1. The lancet specialty journals press releases
2. Physicians call for increased funding for federal infectious disease programs
3. Mailman School of Public Health researchers develop infectious disease diagnostic tool
4. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
5. NIAID launches program to improve medical tools against emerging infectious diseases
6. Study suggests better use of web could improve infectious disease reporting
7. International public health expert Jeffrey Koplan addresses emerging infectious diseases conference
8. Two centres for infectious diseases established
9. Expert guide to infectious diseases published
10. Stress may increase susceptibility to infectious disease
11. First mouse model for multiple system atrophy points to new treatment targets for brain diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... On Thursday, the Triangle ... Work in the Research Triangle for 2017. , Winners were chosen based on ... meet a threshold in employee participation--a percentage that varies based upon the size ...
(Date:9/20/2017)... ... 20, 2017 , ... Doctors on Liens has added the medical group Bones ... working on a personal injury lien basis. Founded by Dr. Wayne Cheng, MD and ... vast experience with orthopedic injuries to patients in the Inland Empire. , Bones and ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... much-anticipated fall event , Look Awesome This Autumn with CoolSculpting®. Scheduled for ... pricing and refreshments. , Mirror Mirror Beauty Boutique is Houston’s largest ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that Clear ... commercial support services market) has entered into an agreement on September 1, 2017 ... The PGSD is the first private Dental School to launch an online, accredited ...
(Date:9/20/2017)... ... ... Compliancy Group is proud to announce that its proprietary ... long-time client pass their Department of Health and Human Services (HHS) Office for ... the help of the Compliancy Group's Audit Response Program™, not a single client ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir ... Smart Spirometer, announced today a partnership with Novartis Pharma AG ... solidifies NuvoAir,s position as the leading mobile spirometry platform and ... patients. ... test ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology:
Cached News: